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CASE REPORT Open Access
Frameshift mutation hotspot identified in
Smith-Magenis syndrome: case report and
review of literature
Hoa T Truong1,4,5, Tracy Dudding2,3, Christopher L Blanchard1, Sarah H Elsea4*
Abstract
Smith-Magenis syndrome (SMS) is a complex syndrome involving intellectual disabilities, sleep disturbance,
behavioural problems, and a variety of craniofacial, skeletal, and visceral anomalies. While the majority of SMS cases
harbor an ~3.5 Mb common deletion on 17p11.2 that encompasses the retinoic acid induced-1 (RAI1) gene, some
patients carry small intragenic deletions or point mutations in RAI1. We present data on two cases of Smith-Magenis
syndrome with mutation of RAI1. Both cases are phenotypically consistent with SMS and RAI1 mutation but also have
other anomalies not previously reported in SMS, including spontaneous pneumothoraces. These cases also illustrate
variability in the SMS phenotype not previously shown for RAI1 mutation cases, including hearing loss, absence of
self-abusive behaviours, and mild global delays. Sequencing of RAI1 revealed mutation of the same heptameric
C-tract (CCCCCCC) in exon 3 in both cases (c.3103delC one case and and c.3103insC in the other), resulting in frame-
shift mutations. Of the seven reported frameshift mutations occurring in poly C-tracts in RAI1, four cases (~57%) occur
at this heptameric C-tract. Collectively, these results indicate that this heptameric C-tract is a preferential hotspot for
single nucleotide insertion/deletions (SNindels) and therefore, should be considered a primary target for analysis in
patients suspected for mutations in RAI1. We expect that as more patients are sequenced for mutations in RAI1, the
incidence of frameshift mutations in this hotspot will become more evident.
Background
Smith-Magenis syndrome (SMS, OMIM182290) is a
complex syndrome involving intellectual disabilities,
sleep disturbance, behavioural problems, and a variety of
craniofacial, skeletal, and visceral anomalies (Table 1).
The majority of SMS cases harbor an ~3.5 Mb common
deletion on 17p11.2 that encompasses the retinoic acid
induced-1 (RAI1) gene, which is the causative gene in
this disorder [1,2]. Patients who do not have a cytogen-
etically detectable deletion of 17p11.2 but whom exhibit
phenotypes consistent with SMS are sequenced for
mutations in RAI1. To date, fourteen patients with point
mutations or small deletions within RAI1 have been
reported in the literature (Table 2) [1,3-6].
Case Presentation
Case 1
SMS324 is an 18-year-old male who was delivered at 38
weeks gestation following premature labor and antepar-
tum haemorrhage. His birth weight was 2,750 g (10th-
50th centile). While his neonatal period was complicated
by gastroesophageal reflux and failure to thrive, he was
admitted to the hospital at 1 year of age for being con-
siderably overweight, with fat folds on his arms and legs.
He spoke his first words at 6 months and walked at
12 months. His medical history includes two episodes of
severe asthma, petit mal seizures between the ages of
5-10 y and three spontaneous pneumothoraces (SP). He
had a square shaped face, upslanting palpebral fissures,
down turned mouth, inverted upper lip, and synophrys
(Fig. 1A). Other physical anomalies included brachydac-
tyly, bilateral fifth finger clinodactyly with a small mid-
dle phalanx of his fifth fingers, and pes planus. At
16 years of age, height was 163 cm (<3rd centile), head
circumference was 54 cm, and he presented with relative
truncal obesity.
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Table 1 Phenotypic features of Smith-Magenis syndrome patients with a 17p11.2 deletion or RAI1 mutation
Clinical findings 17p11.2 deletion (%)* RAI1 mutation (%)* SMS324 SMS335
Craniofacial/skeletal
Brachycephaly 89 81.8 + +
Midface hypoplasia 92 72.7 +/- +
Prognathism (relative to age) 53 88.8 - -
Tented upper lip 73 91.6 + -
Broad square face 81 90.9 + +
Synophyrys 62 33.3 + -
Cleft lip/palate 9 0 - -
Brachydactyly (short fingers, toes) 85 83.3 + +
Short stature 69 9 + +
Scoliosis 49-67 36.3 + +
Otolaryngologic
Chronic ear infections 85 54.5 N +
Hearing loss 68 10 + +
Horse, deep voice 80 100 + -
Neurological/behavioral
Intellectual disability 100 100 + +
Speech delay >90 70 + +
Motor delay >90 70 - +
Hypotonia >90 61 + +
Seizures by history 11-30 16.6 + -
Sleep disturbance 70-100 100 + +
Self-hugging/hand-wringing 70-100 100 - -
Attention-seeking 80-100 100 + +
Self-injurious behaviours 78-96 100 + +
Onychotillomania 25-85 80 - +
Polyemboilokomania 25-85 90 - +
Head-banging/face-slapping 71 60 + -
Ocular
Myopia 53 60 + -
Strabismus 50 40 + +
*Modified from Girirajan et al. 2007; + = present, - = absent, N = unknown/not evaluated.
Table 2 Mutations identified in exon 3 of RAI1
Nucleotide change Amino acid change Mutation
Mutations reported in Exon 3 of RAI1 c.253del19a p.Leu85fsX60 Frameshift
c.1449delCb, † p.Pro483fsX34 Frameshift
c.2773del29b p.Val925fsX8 Frameshift
c.3103insCc, d, † p.Gln1035fsX30 Frameshift
c.3103delCe, f, † p.Gln1035fsX28 Frameshift
c.3801delCa, † p.Pro1267fsX46 Frameshift
c.5265delCb, † p.Pro1755fsX74 Frameshift
c.1119delCg, † p.Ser373fsX65 Frameshift
c.4649delCg, † p.Ser1550fsX36 Frameshift
c.4933delGCCGg p.Ala1645fsX35 Frameshift
c.2878C>Tc p.Arg960X Nonsense
c.3634A>Ge p.Ser1212Gly Missense
c.4685A>Ga p.Gln1562Arg Missense
c.5423G>Aa p.Ser1808Asn Missense
aGirirajan et al. 2005, bSlager et al. 2003, cBi et al. 2004, dSMS334, eBi et al. 2006, fSMS324, g Girirajan et al., 2006, †Frameshift mutations resulting from SNindel in
poly C-tracts.
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Behaviorally, SMS324 exhibited head-banging and
rage attacks starting at age 3. At age 16, he continues
to have recurrent episodes of rage attacks, anxiety, and
obsessional behavior. He has never slept through the
night, with recurrent 3 a.m. wakenings. Apart from fin-
ger chewing, he exhibits no self-injurious behaviors,
self hugging, onychotillomania or polyembolokomania,
which are common behaviors found in SMS patients.
He has had a persistent history of sleep disturbance.
A formal developmental assessment indicated a mild
global developmental delay. He was initially diagnosed
with attention deficit disorder; however, a later assess-
ment indicated this diagnosis was incorrect. He was
initially mainstreamed in a regular classroom at school
but at age 16 now functions in an OI classroom with
supervision. The patient was referred for SMS genetic
Figure 1 Mutation screening of SMS324 for RAI1 and FLCN. A. Photograph of SMS324 at 18y, exhibiting features characteristic of SMS.
B. DNA chromatograph of the normal allele and the c.3103delC change identified, resulting in a frameshift in the mutant allele. This mutation is
located within a heptameric C-tract (red C’s in the normal allele). C. Representation of the gene structure of FLCN transcript variant 1(top) and
transcript variant 2 (bottom). Non-coding exons are blue while coding exons are red. The FLCN polymorphism identified in this patient is
localized with arrows in both transcript variants and is numbered accordingly.
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evaluation based upon phenotypic similarities to SMS
and/or RAI1 mutation patients (Table 1).
Karyotype analysis and 17p11.2 FISH including RAI1
for this patient was normal, as were 22q11.2 FISH and
subtelomeric deletion screening. DNA sequencing of
RAI1, however, revealed a deletion of a single cytosine,
c.3103delC, in a heptameric C-tract (CCCCCCC) of
exon 3 (Fig. 1B). This frameshift mutation predicts the
misincorporation of 28 amino acids before a premature
stop codon is introduced. The resulting truncated pro-
tein is predicted to be non-functional, contributing to
the haploinsufficiency of RAI1.
Case 2
SMS335, a 16-year-old female, was delivered full term
with a birth weight of 3,398 g (90th percentile). The preg-
nancy was unremarkable aside from maternal Macrodan-
tin use for urinary tract infection throughout. At the time
of evaluation, SMS335 was short in stature (10th -25th
percentile), noted to have generalized hypotonia, global
developmental delays, significant hearing loss, truncal
obesity, and commonly observed behaviours of SMS
including sleep disturbance, skin picking, and toenail
removal. For SMS335, phenotypes consistent with SMS/
mutations in RAI1 are noted in Table 1. Chromosome
analyses for fragile-X syndrome, Prader-Willi syndrome
and SMS were normal for this patient. DNA sequencing
performed by GeneDx (Gaithersburg, MD) identified a
c.3103insC, located within the same heptameric C-tract
in exon 3 of RAI1, as noted in SMS324.
Conclusions
Single nucleotide insertion/deletions (SNindels) occur at
an estimated frequency of 1 for every 11,274 bp of the
human genome, with more than half occurring in
regions with mononucleotide repeats. SNindels can arise
from slipped mispairing in regions with repeating units
during DNA synthesis or repair [7]. The c.3103delC and
c.3103insC frameshift mutations reported here were pre-
viously reported as novel mutations in two other
patients [4,5]. Of the seven reported frameshift muta-
tions occurring in poly C-tracts in RAI1, four cases
(~57%) occur at this heptameric C-tract (Table 2). Col-
lectively, these results indicate that this heptameric
C-tract is a preferential hotspot for SNindels resulting
in a frameshift mutation, and therefore, should be con-
sidered a primary target for analysis in patients sus-
pected for mutations in RAI1. We expect that as more
patients are sequenced for mutations in RAI1, the inci-
dence of frameshift mutations in this hotspot will
become more evident (RAI1 sequencing conditions are
available upon request).
Case SMS324 has provided us with an opportunity to
evaluate a possible genetic link underlying his history of
spontaneous pneumothoraces (SP), a phenotype that has
not been documented in any individual with SMS or
mutations in RAI1 evaluated to date. Mutations in the
folliculin (FLCN) gene have been implicated in Birt-Hogg-
Dubé syndrome (BHD, OMIM135150), an autosomal
dominant genodermatosis which predisposes for multiple
fibrofolliculomas, renal carcinoma, lung cysts and SP
[8-11]. Although SMS324 does not have any other features
consistent with BHD aside from the three episodes of SP,
clinical heterogeneity is known to exist amongst indivi-
duals with germline mutations in the FLCN gene. Cases
have been reported whereby patients with mutations of
FLCN exhibit SP without the involvement of fibrofolliculo-
mas or renal tumours [9,12-14].
FLCN is located within the SMS region of chromosome
17 and most cases of SMS due to 17p11.2 deletion are
heterozygously deleted for this gene. It is alternatively
spliced and results in two transcript variants that encode
different isoforms. FLCN transcript variant 1 (RefSeq
NM_144997) encodes the longer isoform of this protein
and is widely expressed in various tissues. Transcript var-
iant 2 (NM_144606) uses an alternative splice site in the
3’ coding region to produce a shorter protein product.
Direct sequencing of the entire coding region of FLCN,
using primers designed based upon the RefSeq, was per-
formed for SMS324. No known causative mutations were
identified. However, we detected a single nucleotide
alteration of unknown significance within an intronic
sequence in the primary transcript, c.871+36G>A, which
is considered to be a non-synonymous variant in FLCN
(Fig. 1C; dbSNP: rs3744124) [Gunji et al., 2007; Cho et
al., 2008; Wei et al., 2009]. Although the coding region of
FLCN is highly conserved across vertebrate species,
rs3744124 mapped to a region of low conservation
amongst 17 vertebral species [Cho et al., 2008].
Alignment of the FLCN polymorphism found in
SMS324 against the sequence of transcript variants 1
and 2 reveals a noteworthy observation. This poly-
morphic change occurs within intron 8 of transcript var-
iant 1 and is expected to have no effect on the
production of a fully functional FLCN isoform 1 protein
in SMS324. However, when aligned against transcript
variant 2 a nucleotide change, c.907G>A, occurs in cod-
ing exon 8 for variant 2, resulting in a missense muta-
tion, p.Gly303Arg (Fig. 1C). Thus, while this DNA
alteration is considered an intronic SNP for variant 1, it
creates a missense mutation in variant 2. Whether or
not this discrepancy is significant or has any bearing on
the SP observed in SMS324 is unclear at this time.
Interestingly, no studies have investigated the frequency
and/or expression of transcript variant 2 in normal or
neoplastic tissues and moreover, if there is an isoform
specific association with certain phenotypes manifested
in BHD, such as SP.
Truong et al. BMC Medical Genetics 2010, 11:142
http://www.biomedcentral.com/1471-2350/11/142
Page 4 of 5
These studies add two interesting cases to the growing
list of mutations in RAI1 that result in SMS and high-
light that key phenotypic differences between patients
may exist, even when the underlying etiology is the
same. Data presented here highlight a specific poly C
tract region within RAI1 that may be more prone to sin-
gle basepair insertion or deletion, with 57% of C tract
RAI1 mutations reported to date. The cases presented
also show that even though RAI1 is the primary gene
causative of features of SMS, that other genes must be
considered in phenotypically complex cases to provide
full recurrence and disease risk information for other
members of the family.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Acknowledgements
We sincerely thank SMS324 and SMS335 and their families for participating
in our study. We are indebted to Dr. Laura Schmidt for providing FLCN
primers for sequencing and discussions on BHD. Patient enrollment and
sample collection in this study were in accordance to approved IRB
protocols by either Virginia Commonwealth University (VCU3784) or Charles
Sturt University (2006/022). This work was funded through resources from
Virginia Commonwealth University to S.H.E.
Author details
1School of Biomedical Sciences, Charles Sturt University, Wagga Wagga,
NSW, Australia. 2Hunter Genetics, Warratah, NSW, Australia. 3University of
Newcastle, Newcastle, NSW, Australia. 4Departments of Pediatrics and Human
Genetics, Virginia Commonwealth University, Richmond, VA, USA. 5Current
Address: KeyGene N.V., Wageningen, The Netherlands.
Authors’ contributions
All authors contributed to the work presented and participated in writing or
reviewing the manuscript. HTT performed the experiments and drafted the
initial manuscript; TD identified cases and collected clinical data; CLB
analysed molecular data and co-supervised the project; and SHE co-
supervised the project, analyzed data, and drafted the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 11 May 2010 Accepted: 8 October 2010
Published: 8 October 2010
References
1. Slager RE, Newton TL, Vlangos CN, Finucane B, Elsea SH: Mutations in RAI1
associated with Smith-Magenis syndrome. Nat Genet 2003, 33(4):466-468.
2. Vlangos CN, Yim DK, Elsea SH: Refinement of the Smith-Magenis
syndrome critical region to approximately 950 kb and assessment of
17p11.2 deletions. Are all deletions created equally? Mol Genet Metab
2003, 79(2):134-141.
3. Girirajan S, Vlangos CN, Szomju BB, Edelman E, Trevors CD, Dupuis L,
Nezarati M, Bunyan DJ, Elsea SH: Genotype-phenotype correlation in
Smith-Magenis syndrome: evidence that multiple genes in 17p11.2
contribute to the clinical spectrum. Genet Med 2006, 8(7):417-427.
4. Bi W, Saifi GM, Girirajan S, Shi X, Szomju B, Firth H, Magenis RE, Potocki L,
Elsea SH, Lupski JR: RAI1 point mutations, CAG repeat variation, and SNP
analysis in non-deletion Smith-Magenis syndrome. Am J Med Genet A
2006, 140(22):2454-2463.
5. Bi W, Saifi GM, Shaw CJ, Walz K, Fonseca P, Wilson M, Potocki L, Lupski JR:
Mutations of RAI1, a PHD-containing protein, in nondeletion patients
with Smith-Magenis syndrome. Hum Genet 2004, 115(6):515-524.
6. Girirajan S, Elsas LJ, Devriendt K, Elsea SH: RAI1 variations in Smith-
Magenis syndrome patients without 17p11.2 deletions. J Med Genet 2005,
42(11):820-828.
7. Tan EC, Li H: Characterization of frequencies and distribution of single
nucleotide insertions/deletions in the human genome. Gene 2006,
376(2):268-280.
8. Schmidt LS, Warren MB, Nickerson ML, Weirich G, Matrosova V, Toro JR,
Turner ML, Duray P, Merino M, Hewitt S, et al: Birt-hogg-dube syndrome, a
genodermatosis associated with spontaneous pneumothorax and kidney
neoplasia, maps to chromosome 17p11.2. Am J Hum Genet 2001,
69(4):876-882.
9. Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, Wei MH,
Schmidt LS, Davis L, Zbar B, et al: Lung cysts, spontaneous pneumothorax,
and genetic associations in 89 families with Birt-Hogg-Dube syndrome.
Am J Respir Crit Care Med 2007, 175(10):1044-1053.
10. Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY,
Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS: Expression of Birt-
Hogg-Dube gene mRNA in normal and neoplastic human tissues. Mod
Pathol 2004, 17(8):998-1011.
11. Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, Walther M,
Choyke P, Weirich G, Hewitt SM, et al: Risk of renal and colonic neoplasms
and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome.
Cancer Epidemiol Biomarkers Prev 2002, 11(4):393-400.
12. Gunji Y, Akiyoshi T, Sato T, Kurihara M, Tominaga S, Takahashi K, Seyama K:
Mutations of the Birt Hogg Dube gene in patients with multiple lung
cysts and recurrent pneumothorax. J Med Genet 2007, 44(9):588-593.
13. Painter JN, Tapanainen H, Somer M, Tukiainen P, Aittomaki K: A 4-bp
deletion in the Birt-Hogg-Dube gene (FLCN) causes dominantly
inherited spontaneous pneumothorax. Am J Hum Genet 2005,
76(3):522-527.
14. Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ,
Turner ML, Choyke PL, Sharma N, Peterson J, et al: Germline BHD-mutation
spectrum and phenotype analysis of a large cohort of families with Birt-
Hogg-Dube syndrome. Am J Hum Genet 2005, 76(6):1023-1033.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2350/11/142/prepub
doi:10.1186/1471-2350-11-142
Cite this article as: Truong et al.: Frameshift mutation hotspot identified
in Smith-Magenis syndrome: case report and review of literature. BMC
Medical Genetics 2010 11:142.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Truong et al. BMC Medical Genetics 2010, 11:142
http://www.biomedcentral.com/1471-2350/11/142
Page 5 of 5
